Safety and effectiveness of sensor-controlled scalp cooling to prevent alopecia in primary breast cancer patients receiving neoadjuvant or adjuvant epirubicin, taxanes, or both

Authors
Category Primary study
JournalCancer Research
Year 2018
This article has no abstract
Epistemonikos ID: 7b320b86d37b550fb6254d59c13b616d23445f4c
First added on: Feb 09, 2025